Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT06445530
Recruiting
Nutrition Optimization and Community Upliftment for Postpartum Recovery
Not applicable · United States · 1 site
Registry update: 22 Sept 2026
NCT07451912
Recruiting
Venetoclax Plus Hypomethylating Agents and Subcutaneous Cytarabine for CEBPA-Mutated AML
Phase 1/2 · China · 1 site
Registry update: 5 Mar 2026
NCT07127861
Recruiting
Effects of Treadmill-Based Gait Training in Patients With Stroke
Not applicable · Spain · 1 site
Registry update: 31 Mar 2026
NCT07176624
Recruiting
The PRE-VAIL Study
Not applicable · China · 1 site
Registry update: 9 Feb 2026
NCT06665646
Recruiting
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
Phase 1 · Peru, United States · 9 sites
Registry update: 18 Sept 2026
NCT07185100
Recruiting
Determination of the Prevalence of Unrecognized Heart Failure Among Patients at Risk in Urban Areas Across Germany Using CMR
Not applicable · Germany · 1 site
Registry update: 1 Apr 2026
NCT07095621
Recruiting
Feasibility and Effectiveness of Three-day Discharge After Distal Pancreatectomy
Not applicable · Italy · 1 site
Registry update: 5 Nov 2026
NCT07062198
Recruiting
Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease
Phase 3 · 8 sites
Registry update: 6 Feb 2026
NCT07003529
Recruiting
Role of Inferior Colliculi in Auditory Hallucinations
Not applicable · France · 1 site
Registry update: 9 Dec 2025
NCT07179692
Recruiting
CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors
Phase 1 · China · 1 site
Registry update: 2 Oct 2025
NCT07205887
Recruiting
A Dose-masked Study of Intravitreal Remigromig (EYE103) in Participants With NVAMD or Macular Edema Following BRVO
Phase 2 · United States · 55 sites
Registry update: 20 Oct 2026
NCT07284992
Recruiting
SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC
Phase 2 · China · 1 site
Registry update: 16 Dec 2025
2024-520287-34-01
Recruiting
A phase II randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of an oral solution of 9-Δ tetrahydrocannabinol/cannabidiol (THC/CBD) in multiple sclerosis patients with chronic neuropathic pain
Phase 2 · Portugal · 1 site
Registry update: 23 Feb 2026
NCT07153263
Recruiting
Local Anaesthetic Spread and Sensory Block Range of the Retro-superior Costotransverse Ligament Space Block
Not applicable · China · 2 sites
Registry update: 28 Aug 2026
2024-512914-16-00
Recruiting
A Randomized, Double-blind, Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics and Clinical Effects between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis
Phase 3 · Belgium, Bulgaria, Czechia, Germany, Denmark, Spain, France, Croatia, Italy, Lithuania, Poland, Romania, Sweden, Slovenia, Slovakia · 55 sites
Registry update: 20 Oct 2026
Conflicting statuses (updated in the registry within the last month)
NCT07245095
Recruiting
Premedication With N-acetylcysteine and Simethicone to Improve Mucosal Visualization in Elective Upper Endoscopy
Phase 2 · Mexico · 2 sites
Registry update: 24 Nov 2025
NCT07003321
Recruiting
A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Phase 2 · China · 1 site
Registry update: 18 Dec 2025
NCT07020741
Recruiting
Stable Isotopes- Adults With Obesity
Not applicable · United States · 1 site
Registry update: 29 Apr 2026
NCT06161818
Recruiting
Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction
Phase 2 · Netherlands · 15 sites
Registry update: 22 Dec 2025
NCT07207057
Recruiting
Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform Trial
Phase 3 · United Kingdom · 2 sites
Registry update: 3 Oct 2025

Ordered by registry start date. Freshness and sponsorship never change the order.